Investigation to assess the efficacy of benzyl benzoate 10/25% emulsion versus oral ivermectin for scabies treatment
Phase 4
- Conditions
- B86Scabies
- Registration Number
- DRKS00026602
- Lead Sponsor
- niversitätsklinik für Dermatologie, Paracelsus Medizinische Universität Salzburg (PMU)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 224
Inclusion Criteria
diagnosis of scabies (dermatoscopically confirmed)
Exclusion Criteria
Scabies crutosa
- pre-treatment with topical Benzyl Benzoate XML File Identifier: bekvJUBdLZKFbixLby3v6TN1L5w=
Page 18/28
- use of topical Permethrin (e.g. Infectoscab 5% Creme®) within the last 2 weeks (child <6 years) or 3 weeks (age = 6years)
- sufficient use of oral ivermectin within the last 3 months
- allergy or intolerance agains top. benzyl benzoate Emulsion
- mental disfunction
- pregnancy/breast-feeding
- alcohol abuse
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method cure rate of topical benzyl benzoate versus oral ivermectin in treating scabies
- Secondary Outcome Measures
Name Time Method